Home Team will develop and produce premium television projects with UIS for the UK and global market
C4X Discovery continues its progress with the signing of an exclusive global license with AstraZeneca.
Calculus completes exit from Avvio for 5.5x return, a continuation of excellent exits achieved for Calculus investors in the last two years.
The Government is committed to helping entrepreneurial businesses raise growth capital by continued support of EIS and VCT. Dividend and capital gains tax allowances are being reduced, and the threshold of top rate tax drops, so EIS and VCT tax reliefs are more valuable now than ever. The Autumn Statement was a defining moment for … Continued
Destiny Pharma’s potentially revolutionary product ‘XF-73’ progresses into next stage study.
80% of OEM’s customers won’t have to rely on taxpayer support this winter Saving taxpayers over £250m versus full energy price cap payouts Keeping hundreds of businesses afloat and in control of their costs Open Energy Market (OEM), a leading provider of energy procurement services and net zero technologies, today quantifies the taxpayer savings made … Continued
Calculus sponsored the HNW wealth manager of the year award.